Patients are Asking – MPN Expert
Dr. Abu-Zeinah discusses
Ropeginterferon, FDA Approved
Treatment for Polycythemia Vera
Episode 3 of 3
Ropeginterferon / BESREMi was recently approved by the FDA to treat Polycythemia Vera. Patients are asking: Should I switch from Pegasys to the new FDA approved Ropeginterferon? How might Ropeginterferon change the treatment paradigm for lowrisk PV or PV in general?
Stay tuned as there will be a Part 2 video continuing this important discussion.
Dr. Ghaith Abu-Zeinah, Assistant Professor at Weill Cornell Medical College, Silver MPN Center is our MPN specialist answering these questions and more.
David Wallace, PV Reporter, is your host and patient advocate.